Farida Latif - Concepedia

Author

Farida Latif

Also Known As

F Latif, F. Latif, FARIDA LATIF, Fadi Abdul Latif, Farida Latif, Fatma El Zahraa Mohammed Abd El Latif, Febrianti Latif, J Y Wu, L. Geil, Latif, Farida

315

Publications

23.8K

Citations

H-Index

104

Concepts

All Affiliations

University of Birmingham National Cancer Institute Cancer Research UK University of Cambridge Birmingham Women's Hospital

About

Farida Latif is an author at University of Birmingham specializing in medicine, tumor biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	58	87	13.5K
2	Natural Sciences	9	9	680
3	Health Sciences	3	3	303
4	Engineering	2	2	194
5	Biology	1	1	11

Farida Latif

147

Publications

22.1K

Citations

H-Index

Page 1

	Year	Citations
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene Farida Latif, Kálmán Tory, James R. Gnarra, Science	1993	3K
Mutations of the VHL tumour suppressor gene in renal carcinoma James R. Gnarra, Kálmán Tory, Y Weng, Nature Genetics UrologyGenitourinary CancerKidney ResearchRenal PathologyPathology	1994	1.7K
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. James G. Herman, Farida Latif, Y Weng, Proceedings of the National Academy of Sciences Epigenetic ChangeDna MethylationPathologyEpigeneticsTumor Biology	1994	1.5K
Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma Dewi Astuti, Farida Latif, Ashraf Dallol, The American Journal of Human Genetics Somatic VariantFamilial PheochromocytomaGenetic DisorderGeneticsInherited Metabolic Disease	2001	1.1K
Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression David G. Burbee, Éva Forgács, Sabine Zöchbauer‐Müller, JNCI Journal of the National Cancer Institute	2001	769
Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotype Fan Chen, Takeshi Kishida, Masahiro Yao, Human Mutation GeneticsPathologyDisease Gene IdentificationTumor BiologyClinical Genetics	1995	562
Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Taro Shuin, Keiichi Kondo, Soichiro Torigoe, PubMed Renal PathologyPathologyTumor BiologyCarcinomaGenitourinary Cancer	1994	473
High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Ignacio I. Wistuba, Carmen Behrens, Arvind K. Virmani, PubMed GeneticsPathologyCancer BiologyTumor BiologyTumor Heterogeneity	2000	406
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours Angelo Agathanggelou, Sofia Honorio, Donia Macartney‐Coxson, Oncogene Region 3P21.3MedicineOvarian TumoursPathologyCancer Cell Biology	2001	377
Germline SDHB Mutations and Familial Renal Cell Carcinoma Christopher J. Ricketts, Emma R. Woodward, Pip Killick, JNCI Journal of the National Cancer Institute	2008	339

Page 1